| 000 | 01648 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515015259.0 | ||
| 264 | 0 | _c20060711 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/j.lfs.2006.01.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuinzberg, Raquel | |
| 245 | 0 | 0 |
_aIn rat hepatocytes, different adenosine receptor subtypes use different secondary messengers to increase the rate of ureagenesis. _h[electronic resource] |
| 260 |
_bLife sciences _cJun 2006 |
||
| 300 |
_a382-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xmetabolism |
| 650 | 0 | 4 | _aAdenylyl Cyclase Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aEgtazic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 |
_aImines _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xmetabolism |
| 650 | 0 | 4 |
_aSecond Messenger Systems _xdrug effects |
| 650 | 0 | 4 |
_aUrea _xmetabolism |
| 700 | 1 | _aUribe, Salvador | |
| 700 | 1 | _aDíaz-Cruz, Antonio | |
| 700 | 1 | _aHernández Cruz, Arturo | |
| 700 | 1 | _aPiña, Enrique | |
| 773 | 0 |
_tLife sciences _gvol. 79 _gno. 4 _gp. 382-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2006.01.021 _zAvailable from publisher's website |
| 999 |
_c16106000 _d16106000 |
||